This map shows the geographic impact of M. Pinget's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Pinget with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Pinget more than expected).
This network shows the impact of papers produced by M. Pinget. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Pinget. The network helps show where M. Pinget may publish in the future.
Co-authorship network of co-authors of M. Pinget
This figure shows the co-authorship network connecting the top 25 collaborators of M. Pinget.
A scholar is included among the top collaborators of M. Pinget based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with M. Pinget. M. Pinget is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Rouch, Laure, Philippe Cestac, Brigitte Sallerin, et al.. (2019). Abstract 11958: Visit-to-visit Blood Pressure Variability is Associated With Cognitive Decline and Incident Dementia: The S.AGES Cohort. Circulation.1 indexed citations
Pinget, M., et al.. (2014). Le stress oxydant : nouvelle cible pour optimiser la prise en charge du patient diabétique de type 1.. SPIRE - Sciences Po Institutional REpository.1 indexed citations
Soell, Martine, et al.. (2010). CHROMOGRANIN A DETECTION IN SALIVA OF TYPE 2 DIABETES PATIENTS. SHILAP Revista de lepidopterología.2 indexed citations
11.
Zinman, Bernard, Greg Fulcher, Nihal Thomas, et al.. (2010). Insulin degludec, a new generation ultra-long acting insulin, used once daily or 3-times weekly in people with type 2 diabetes: comparison to insulin glargine. Diabetes. 59.5 indexed citations
Pinget, M., et al.. (2001). Le diabète de type 2. Médecine Nucléaire. 25(2). 103–114.
14.
Leprêtre, Frédéric, et al.. (1999). Type 2 diabetes mellitus: association study of five candidate genes in an Indian population of Guadeloupe, genetic contribution of FABP2 polymorphism.. PubMed. 25(2). 150–6.52 indexed citations
15.
Lassmann‐Vague, V., Bruno Guerci, H Hanaire-Broutin, et al.. (1997). Use of implantable insulin pumps: the EVADIAC position. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases). Evaluation dans le Diabete du Traitement par Implants Actifs.. PubMed. 23(3). 234–50.10 indexed citations
16.
Basdevant, A, G Cathelineau, Patrick Fénichel, et al.. (1996). Grossesse et contraception chez la femme diabetique. Diabete gestationnel. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases).. Diabetes & Metabolism. 22(6).6 indexed citations
Pinget, M., et al.. (1982). Tolérance glucosée de la femme enceinte.. Pathologie Biologie. 30(1).
19.
Brogard, Jean‐Marie, et al.. (1982). Biliary Excretion of Cefaclor. Chemotherapy. 28(3). 189–199.4 indexed citations
20.
Pinget, M., et al.. (1979). Dépistage des états diabétiques au cours de la grossesse.. 130(12).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.